SCHEMBL9253635

SCHEMBL9253635

Clc1nnc(-c2ccsc2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.42
CYP2B6 P20813 2/20 0.42
CYP2E1 P05181 1/20 0.42
TDO2 P48775 1/20 0.42
GOT1 P17174 1/20 0.40
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NQO2 P16083 1/20 0.37
HPGD P15428 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
GFER P55789 1/20 0.37
NPY5R Q15761 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP3A4 P08684 1/20 0.36
CASP3 P42574 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13996078 0.84 CYP2A6 (0.57) CYP2A6CYP2B6CYP2E1TDO2MAPT
SCHEMBL2404513 0.79 KDM4E (0.52) CYP2A6CYP2B6CYP2E1TDO2NQO2
SCHEMBL8552712 0.79 ENPP1 (0.38) CYP2A6CYP2B6CYP2E1TDO2NQO2
SCHEMBL29537275 0.77 MAPT (0.49) GOT1MAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL580414 0.77 MAPT (0.49) GOT1MAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL31359722 0.74 KMT2A (0.57) GOT1MAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL1396090 0.74 KMT2A (0.57) GOT1MAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL29365992 0.72 GOT1 (0.62) CYP2A6GOT1MAPTALDH1A1SMN1; SMN2
SCHEMBL345211 0.72 GOT1 (0.62) CYP2A6GOT1MAPTALDH1A1SMN1; SMN2
SCHEMBL1268020 0.71 ESR1 (0.49) GOT1MAPTALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5462941-A 1-(cyclohexylalkylamino)-4-(phenyl, thienyl, or furyl) phthalazines; anti-platelet agglutination agents for treatment or prevention of cerebro- or cardiovascular disorders MITSUBISHI CHEMICAL CORPORATION (JP) 1995-10-31 US disclosed
EP-0534443-A1 3,6-Disubstituted pyridazine derivatives Mitsubishi Chemical Corporation (JP) 1993-03-31 EP disclosed